glp 1 ra drug names GLP-1 Comparison in Diabetes and Obesity Treatment GLP-1 Receptor Agonists: The New
Description
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
Advanced Metabolic Signaling Research
Ph 2 datathat showed weight loss of between 9.4% and 14.7% after 36 weeks on the drug compared to 2.3% for the placebo group and is currently in Ph 3
Promising clinical trial data suggests big opportunity with Eli Lilly's retatrutide GLP-1 candidate.
